(Q43039673)

English

Impact of calcineurin inhibitors with or without interferon on hepatitis C virus titers in a chimeric mouse model of hepatitis C virus infection

scientific article published in January 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Impact of calcineurin inhibitors with or without interferon on hepatitis C virus titers in a chimeric mouse model of hepatitis C virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Norman M Kneteman

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sonal Asthana

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jamie Lewis

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Chelcey Dibben

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Donna Douglas

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Mahra Nourbakhsh

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Lorne J Tyrrell

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Garry Lund

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Liver Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

38-44

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Reinfection of liver graft by hepatitis C virus after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

A longitudinal analysis of hepatitis C virus replication following liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

HCV-related fibrosis progression following liver transplantation: increase in recent years

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Hepatitis C virus replication in mice with chimeric human livers

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA Replication In Vitro

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Cyclosporine Inhibits a Direct Interaction between Cyclophilins and Hepatitis C NS5A

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A

1 reference

https://api.crossref.org/works/10.1002%2FLT.22400

21 January 2018

Identifiers

10.1002/LT.22400

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43039673&oldid=1978310676"